Cooling in surgical patients: two case reports

Bibi F Gurreebun1, Christos S Zipitis2, Ngozi E Edi-Osagie3

  • 1Neonatal Unit, Royal Albert Edward Infirmary, Wrightington Wigan and Leigh NHS Foundation Trust, Wigan Lane, Wigan WN1 2NN, UK.

Case Reports in Pediatrics
|February 20, 2014
PubMed

Insights

Moderate induced hypothermia is beneficial for newborns with hypoxic-ischaemic encephalopathy. This case study shows therapeutic hypothermia can be safely used in infants requiring surgery, even with congenital conditions.

Area of Science:

  • Neonatal Medicine
  • Pediatric Surgery
  • Critical Care

Background:

  • Moderate induced hypothermia is standard care for peripartum hypoxic-ischaemic encephalopathy (HIE).
  • Neonates with congenital abnormalities requiring surgery have been excluded from HIE cooling trials due to surgical risks.

Purpose of the Study:

  • To report successful therapeutic hypothermia in two neonates with congenital conditions requiring surgical intervention.
  • To evaluate the safety and feasibility of cooling in this high-risk population.

Main Methods:

  • Two neonates meeting criteria for therapeutic hypothermia, one with duodenal atresia and another with congenital diaphragmatic hernia, were medically stabilized.
  • Therapeutic hypothermia was initiated, and potential complications, including coagulation defects, were monitored and managed.
  • Patients underwent successful surgical intervention after completion of hypothermia.

Main Results:

  • Both neonates tolerated therapeutic hypothermia without significant complications.
  • Medical stabilization and successful surgical repair were achieved in both cases.
  • The study demonstrates the feasibility of combining hypothermia with surgical management.

Conclusions:

  • Neonates with congenital conditions requiring surgery should not be excluded from therapeutic hypothermia if indicated for HIE.
  • Careful monitoring and management can mitigate potential risks associated with cooling in surgical neonates.
  • This approach may improve outcomes for infants with HIE and surgical comorbidities.